Search results

• 2022

  The prevalence of mucus plugging in severe eosinophilic asthma and its relationship to clinical efficacy of anti–IL-5R treatment

  Hearn, A. P., Mak, M. S., Budaj, I., Qurashi, N., Snell, O., Dhariwal, J., Nanzer, A. M. & Jackson, D. J., Apr 2022, In: Journal of Allergy and Clinical Immunology: In Practice. 10, 4, p. 1102-1103.e1

  Research output: Contribution to journal › Article › peer-review
  9 Citations (Scopus)
• 2021

  Real World Effectiveness of Benralizumab in Severe Eosinophilic Asthma

  Kavanagh, J. E., Hearn, A. P., Dhariwal, J., d'Ancona, G., Douiri, A., Roxas, C., Fernandes, M., Green, L., Thomson, L., Nanzer, A. M., Kent, B. D. & Jackson, D. J., Feb 2021, In: Chest. 159, 2, p. 496-506

  Research output: Contribution to journal › Article › peer-review

  • Eosinophilic 100%
  • Therapeutic Procedure 71%
  • Patient 57%
  • Quality of Life 28%
  • Disease 14%
  206 Citations (Scopus)

• The relationship between FENO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma

  Hearn, A. P., Kavanagh, J., d'Ancona, G., Roxas, C., Green, L., Thomson, L., Fernandes, M., Kent, B. D., Dhariwal, J., Nanzer, A. M. & Jackson, D. J., May 2021, In: Journal of Allergy and Clinical Immunology: In Practice. 9, 5, p. 2093-2096.e1

  Research output: Contribution to journal › Article › peer-review
  55 Citations (Scopus)